You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

CLINICAL TRIALS PROFILE FOR OMNICEF


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Omnicef

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00644774 ↗ A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications Completed Abbott Phase 4 2003-01-01 To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication.
NCT00644891 ↗ Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications Completed Abbott Phase 4 2003-01-01 To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It was designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell.
NCT00644943 ↗ A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media Completed Abbott Phase 4 2003-02-01 The primary objective is to compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg/day ql2hrs for 5 days, to amoxicillin/clavulanate oral suspension 45 mg/kg/day (based on amoxicillin component), in divided doses, q12h for 10 days, in children between 6 months and 6 years of age, with AOM.
NCT00645073 ↗ Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis Completed Abbott Phase 4 2003-11-01 To compare the safety and efficacy of a ten-day course of therapy of cefdinir, 600 mg QD, to a ten-day course of therapy of levofloxacin, 500 mg QD, in the treatment of acute bacterial sinusitis.
NCT00645112 ↗ A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media Completed Abbott Phase 4 2003-11-01 To compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg every 12 hours for 5 days, to azithromycin oral suspension 10 mg/kg/day (Day 1) then 5 mg/kg/day (Days 2-5) for a total of 5 days, in children between 6 months and 6 years of age, with AOM.
NCT00645125 ↗ A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications Completed Abbott Phase 4 2003-01-01 To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It is designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell.
NCT00834535 ↗ Cefdinir Capsules 300 mg, Non-fasting Completed Teva Pharmaceuticals USA Phase 1 2005-07-01 This study will compare the relative bioavailability (rate and extent of absorption) of 300 mg Cefdinir Capsules manufactured and distributed by TEVA pharmaceuticals USA with that of OMNICEF® Capsules by CEPH International Corporation for Abbott Laboratories following a single oral dose (1 x 300mg capsule) in healthy adult subjects administered under non-fasting conditions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Omnicef

Condition Name

Condition Name for Omnicef
Intervention Trials
Healthy 8
Acute Otitis Media 2
Kwashiorkor 1
Marasmus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Omnicef
Intervention Trials
Otitis Media 2
Otitis 2
Sinusitis 1
Adenoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Omnicef

Trials by Country

Trials by Country for Omnicef
Location Trials
United States 61
Poland 1
Malawi 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Omnicef
Location Trials
Arizona 6
Texas 5
Michigan 4
Ohio 4
Kentucky 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Omnicef

Clinical Trial Phase

Clinical Trial Phase for Omnicef
Clinical Trial Phase Trials
Phase 4 7
Phase 1 6
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Omnicef
Clinical Trial Phase Trials
Completed 13
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Omnicef

Sponsor Name

Sponsor Name for Omnicef
Sponsor Trials
Abbott 6
Teva Pharmaceuticals USA 4
St. Joseph's Hospital and Medical Center, Phoenix 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Omnicef
Sponsor Trials
Industry 11
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.